Fragment 176-191
January 25, 2024Incremental
3/10
Purrptide digest
Fragment 176-191 is actually the same molecule as AOD9604 — just the more technical name researchers use to refer to the exact 16-amino-acid segment of GH involved. It's marketed separately in some grey-market circles, which causes more confusion than it should given it's the identical compound under a different label. The science is the same: targeted lipolysis (fat breakdown) without the systemic effects of full growth hormone.
What this means for you
🏃
If you care about weight/health
Functionally identical to AOD9604 — if you're comparing the two for purchase, you're comparing the same molecule under different branding.
🩺
If you're a clinician
Worth clarifying to patients that this and AOD9604 are the same compound — naming confusion in the grey market is common here.
🔬
If you're a researcher
The naming divergence between research literature and commercial markets for an identical compound is its own minor case study.
💸
If you follow biotech
Two brand names for one molecule is a marketing quirk, not a separate product — worth knowing before any due diligence.
HE
Heffernan et al.
Monash University
For the nerds
The lipolytic and anti-lipogenic effects of the AOD9604 GH fragment
Diabetes, Obesity and Metabolism · DOI: 10.1046/j.1463-1326.2001.00126.x
Read full paper on PubMed →